Andrew D. Lipman Sells 2,000 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 2,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $12.34, for a total transaction of $24,680.00. Following the completion of the transaction, the director now directly owns 25,225 shares in the company, valued at approximately $311,276.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Nu Skin Enterprises Stock Up 0.6 %

NYSE NUS opened at $12.32 on Friday. Nu Skin Enterprises, Inc. has a twelve month low of $11.84 and a twelve month high of $40.68. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.28 and a current ratio of 2.13. The stock has a market cap of $608.61 million, a PE ratio of 68.42 and a beta of 1.11. The firm has a 50-day simple moving average of $12.74 and a 200 day simple moving average of $16.30.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.08. The business had revenue of $488.64 million for the quarter, compared to analysts’ expectations of $479.35 million. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. On average, research analysts forecast that Nu Skin Enterprises, Inc. will post 1.13 EPS for the current year.

Nu Skin Enterprises Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 6th. Investors of record on Monday, February 26th were given a $0.06 dividend. This represents a $0.24 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 133.34%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. DA Davidson lowered their target price on shares of Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 5th. StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $23.67.

Institutional Investors Weigh In On Nu Skin Enterprises

A number of institutional investors have recently added to or reduced their stakes in the stock. SummerHaven Investment Management LLC lifted its position in shares of Nu Skin Enterprises by 2.4% during the 4th quarter. SummerHaven Investment Management LLC now owns 24,107 shares of the company’s stock worth $468,000 after buying an additional 564 shares during the period. CWM LLC raised its stake in Nu Skin Enterprises by 38.4% during the first quarter. CWM LLC now owns 3,286 shares of the company’s stock worth $45,000 after acquiring an additional 911 shares in the last quarter. Signaturefd LLC lifted its holdings in shares of Nu Skin Enterprises by 25.1% during the fourth quarter. Signaturefd LLC now owns 5,000 shares of the company’s stock valued at $97,000 after acquiring an additional 1,004 shares during the period. Swiss National Bank boosted its stake in shares of Nu Skin Enterprises by 1.0% in the 3rd quarter. Swiss National Bank now owns 109,700 shares of the company’s stock valued at $2,327,000 after purchasing an additional 1,100 shares in the last quarter. Finally, Gladius Capital Management LP grew its holdings in shares of Nu Skin Enterprises by 18.7% in the 4th quarter. Gladius Capital Management LP now owns 9,967 shares of the company’s stock worth $194,000 after purchasing an additional 1,570 shares during the last quarter. 82.84% of the stock is owned by institutional investors and hedge funds.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.